225 filings
D
Prolung Inc
21 Dec 20
$6M in debt, sold $182K, 4 investors
6:10am
10-Q
2020 Q2
Prolung Inc
Quarterly report
16 Sep 20
4:19pm
10-Q
2020 Q1
Prolung Inc
Quarterly report
25 Aug 20
4:38pm
10-K
2019 FY
Prolung Inc
Annual report
15 Jul 20
4:51pm
8-K
Prolung Inc
28 May 20
ProLung announces corporate name change to IONIQ Sciences to reflect expanded early cancer detection strategy
6:05am
8-K
t15wpfz v3mxc
22 May 20
Unregistered Sales of Equity Securities
5:23pm
8-K
zflg va8mdf
10 Mar 20
Changes in Registrant's Certifying Accountant
5:08pm
8-K
86kfx1cdc7fm6a2
27 Feb 20
Submission of Matters to a Vote of Security Holders
12:00am
8-K
fc7i4bx2rw k27i7zp
13 Feb 20
ProLung Test™ Granted ‘Breakthrough Device’ Designation by the FDA
5:19pm
8-K
u4ljjm41a5w3ie860z6d
13 Feb 20
Regulation FD Disclosure
12:00am
DEFA14A
45cm0k0d
13 Jan 20
Additional proxy soliciting materials
12:00am
DEFA14A
fn2y2alv8
31 Dec 19
Additional proxy soliciting materials
5:22pm
DEFA14A
jvqhl33vr z2jf
31 Dec 19
Additional proxy soliciting materials
5:17pm
8-K
210tnd5iqmwkz
27 Nov 19
Other Events
11:04am
8-K
revnus
26 Nov 19
ProLung Announces Change to its Board of Directors
3:27pm
8-K
ob822z47ix1rfx25rdnx
3 Oct 19
ProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 74% specificity
4:00pm
NT 10-Q
a6ouatfq
12 Aug 19
Notice of late quarterly filing
5:29pm